| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Sunday, September 03, 2017 2:57:15 PM
6 months is a number you hear for every milestone for NWBO ever, so just based upon the fact that we are talking about NWBO where everything is "six months away" I do not have to substantiate the claim.
Similarly, if I said "by the end of December 20__" you could take that at face value, though maybe not on say December 15, 20__ because by then reality sets in each year, especially when the ASM comes and goes with no webcast, transcript or news. And the few people who go, get convinced not to share what they found out, because of course, what the company says to its own shareholders couldn't stand up to scrutiny by critics.
But let's take your figure of 3 months and apply the following formula for anything with NWBO.
3 months x 2 (the 'NWBO Drag A$$ Factor') = 6 months.
I base all of this upon the painful experience of hearing a lot of exciting talk about milestones etc. only for us all to get our hopes crushed again and again.
What you call 'fake nonsense' I call having lived the history here and learned from it.
Similarly, if I said "by the end of December 20__" you could take that at face value, though maybe not on say December 15, 20__ because by then reality sets in each year, especially when the ASM comes and goes with no webcast, transcript or news. And the few people who go, get convinced not to share what they found out, because of course, what the company says to its own shareholders couldn't stand up to scrutiny by critics.
But let's take your figure of 3 months and apply the following formula for anything with NWBO.
3 months x 2 (the 'NWBO Drag A$$ Factor') = 6 months.
I base all of this upon the painful experience of hearing a lot of exciting talk about milestones etc. only for us all to get our hopes crushed again and again.
What you call 'fake nonsense' I call having lived the history here and learned from it.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
